🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of Tylenol, claiming the companies withheld safety concerns that the medication presented to pediatric brain development.

The lawsuit arrives four weeks after President Donald Trump advocated an unproven link between using acetaminophen - alternatively called acetaminophen - during pregnancy and autism in children.

Paxton is suing J&J, which formerly manufactured the drug, the sole analgesic suggested for pregnant women, and the current manufacturer, which currently produces it.

In a statement, he said they "deceived the public by profiting off of discomfort and pushing pills regardless of the risks."

Kenvue states there is insufficient reliable data linking Tylenol to autism.

"These companies lied for decades, intentionally threatening millions to boost earnings," the attorney general, from the Republican party, declared.

The manufacturer said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the safety of paracetamol and the likely effects that could have on the welfare of US mothers and children."

On its online platform, Kenvue also stated it had "continuously evaluated the relevant science and there is insufficient valid information that shows a established connection between using paracetamol and autism spectrum disorder."

Organizations acting on behalf of doctors and health professionals concur.

ACOG has stated paracetamol - the main ingredient in acetaminophen - is a restricted selection for women during pregnancy to manage pain and fever, which can pose major wellness concerns if left untreated.

"In over twenty years of investigation on the utilization of paracetamol in pregnancy, zero credible investigations has successfully concluded that the consumption of paracetamol in any trimester of pregnancy causes brain development issues in offspring," the organization commented.

The lawsuit cites current declarations from the Trump administration in claiming the drug is reportedly hazardous.

In recent weeks, Trump caused concern from medical authorities when he told pregnant women to "resist strongly" not to take acetaminophen when unwell.

The FDA then issued a notice that medical professionals should consider limiting the use of acetaminophen, while also stating that "a proven link" between the drug and autism spectrum disorder in minors has not been proven.

Health Secretary Kennedy, who manages the FDA, had pledged in April to initiate "extensive scientific investigation" that would identify the cause of autism spectrum disorder in a matter of months.

But experts cautioned that finding a unique factor of autism - considered by experts to be the outcome of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism is a type of lifelong neurodivergence and disability that influences how persons perceive and engage with the environment, and is diagnosed using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is seeking US Senate - alleges Kenvue and Johnson & Johnson "willfully ignored and tried to quiet the research" around acetaminophen and autism spectrum disorder.

The case seeks to make the corporations "remove any marketing or advertising" that asserts Tylenol is reliable for pregnant women.

The court case echoes the concerns of a assembly of parents of young ones with autism spectrum disorder and ADHD who took legal action against the producers of acetaminophen in two years ago.

Judicial authorities rejected the legal action, saying research from the plaintiffs' authorities was not conclusive.